Dear Sir/Ma''am, Please find additional details required for the Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Janak Raj Sharma (DIN: 07420418), Independent Director of Omkar Pharmachem Ltd, completed his two consecutive five-year terms and ceased to be an Independent Director with effect from 12th February 2026. The company filed the related intimation on 14th February 2026 — two days late instead of within the SEBI-prescribed 24-hour window. The company explained that they believed the cessation intimation needed to be filed only after the Board took it on record, which occurred at the 14th February 2026 Board Meeting. They have expressed regret for the inadvertent delay and sought the exchange's understanding.
The tenure end is a routine regulatory event (mandatory after two consecutive 5-year terms under the Companies Act), so there is no change in business direction for shareholders. However, the delayed filing flags a minor SEBI LODR compliance lapse, though it is unlikely to move the stock price materially.